Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

REBORN

Financiado

REMODELLING OF THE INFARCTED HEART: PIEZOELECTRIC MULTIFUNCTIONAL PATCH ENABLING...

REMODELLING OF THE INFARCTED HEART: PIEZOELECTRIC MULTIFUNCTIONAL PATCH ENABLING THE SEQUENTIAL RELEASE OF THERAPEUTIC FACTORS Cardiac disease remains a major societal and healthcare burden that affect nearly two million European citizens every year. The REBORN project brings together a consortium of six scientific, four SME, and two large company partner... ver más

31/12/2026

POLITO

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

POLITECNICO DI TORINO No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 13 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-11-29

HORIZON-CL4-2022-RESILIENCE-01-13: Smart and multifunctional biomateri... ExpectedOutcome:Multi-functional biomaterials are capable, by virtue of their own material ingredien...

I+D

Cerrada hace 2 años

0% 100%

13 Participantes

POLITO

947.50K€ | Lider

BIOINICIA

305.67K€ | Participante

I3S INSTITUTO DE INVESTIGAC...

350.39K€ | Participante

UNEW

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PiezoMac Piezoceutical biomaterial scaffolds for immunomodulatory-bas... 3M€ Cerrado

SAF2011-30067-C02-01 DESARROLLO DE BIOIMPLANTES PARA LA REGENERACION CARDIACA CON... 254K€ Cerrado

RTI2018-096320-B-C22 DESARROLLO DE NUEVOS BIOMATERIALES Y SISTEMAS ASOCIADOS PARA... 218K€ Cerrado

PID2021-125124OB-I00 COMBINACION DE BIOMATERIALES 3D Y MIRNAS PARA LA REPARACION... 290K€ Cerrado

SAF2014-59892-R POTENCIAL DE LOS CARDIOMIOCITOS DERIVADOS DE CELULAS PLURIPO... 242K€ Cerrado

RTI2018-096320-B-C21 BIOINGENIERIA DE CONSTRUCTOS BASADOS EN BIOMATERIALES PARA L... 182K€ Cerrado

Duración del proyecto: 49 meses Fecha Inicio: 2022-11-29
Fecha Fin: 2026-12-31

Líder del proyecto

POLITECNICO DI TORINO No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Descripción del proyecto Cardiac disease remains a major societal and healthcare burden that affect nearly two million European citizens every year. The REBORN project brings together a consortium of six scientific, four SME, and two large company partners who are committed to making a step-change to the development of medical devices for cardiac applications for the treatment of people who have suffered from a heart attack (myocardial infarction, MI). A MI causes fibrosis in the heart walls, which impedes cardiac function and means there is a high risk of subsequent heart failure post-MI. There are no current treatment options to address this major clinical problem. The REBORN project will use smart and multifunctional biomaterials to deliver a new medical device in the form of a cardiac patch, to be applied to the heart in order to stimulate and support local heart tissue remodelling. The piezoelectric patch will electromechanically couple with the heart and deliver anti-inflammatory, anti-fibrotic and cardiomyocyte proliferative factors on demand, with drug release triggered by ultrasonic (US) stimulation from outside the body. Development of the device will be based on new smart multifunctional materials: electrospun piezoelectric fibres combined with smart carriers designed to work in harmony with the US. To prepare the ground for exploitation, the patch will be extensively characterised in vitro and in vivo. Accelerating the development of the patch requires an effective in vitro model for experimentation, and novel 3D bioprinting techniques will be exploited to create a 3D in vitro model in the form of a tissue engineered tubular heart chamber, capable of pumping fluid using cell contractile forces. This will give a new in vitro model capable of both functional and structural testing. The REBORN project will develop, validate and prepare for the exploitation new treatment options for post-MI fibrosis and new processes for cardiac therapy development, addressing major unmet cli

Conecta tu I+D

Entra hoy

¿Olvide mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores